Here’s a question that occurs only to madmen and geneticists: How do you get a gene that kills an organism to spread through a whole population of that organism?
You can either make your gene deadly, and thus impossible to pass on, or not, and thus useless as a vector of attack. The solution has long been to try “silent” genes that can spread with no negative effects, either introducing a deadly weakness to a man-made chemical we withhold for a while, or by waiting for deadly activation by such a chemical. But recently, with the advent of advanced new in vivo gene editing technology, it’s become possible to make genes that seem to defy evolution — and that means we could soon start releasing animals carrying doomsday genes that spread with astonishing speed, quickly killing entire populations.
Such an animal is currently sitting in a laboratory at Imperial College London, an apocalypse mosquito carrying a gene that could one day end its entire species. It represents a controversial proposal to end the scourge of malaria, which kills hundreds of thousands of people each and every year, by wiping out the mosquitoes that spread the disease. It also represents a fundamentally new ability for humanity: the power to easily and selectively snuff out a subcategory of life on Earth. The name for this power is called gene drive.
Gene drive is simply the use of some strategy to artificially increase a gene’s inheritance rate. Such strategies are found all over nature, but despite decades of theorizing, nobody had a really viable way for mankind to harness this functionality through biotechnology. That’s changed thanks to the incredible advances in direct gene editing we’ve seen over the past half-decade, in particular the CRISPR/Cas9 gene editing suite.
These “molecular scissors” are actually borrowed from viruses, allowing scientists to swap out a gene in a living organism for one of their choice, edit it right into the genome so it will be passed on as the cells reproduce. If you can get your gene spliced into the “germ cells,” the pre-sperm or -egg cells of these organisms, then you can even introduce a chance that it will be passed on to the next generation — classically, without gene drive, you can introduce a 50% chance.
The chance is 50% because germ cells, like virtually all other cell types in humans and mosquitoes, have two copies of our genome. When we splice in our attack gene, it will end up sitting across from a second, totally normal copy of the gene it just replaced. This means that when the two copies get pulled apart to form the half-genomes of two new, separate sperm cells, only one of those new sperm cells will have our spliced-in sequence. The other will carry the same gene it would have, regardless.
So, if our spliced-in gene lowers evolutionary fitness, then all that will happen is the other half of the offspring will thrive, and the infected individuals will be quickly bred out of the population. And even if it’s a seemingly harmless silent gene that does nothing at first, it will still spread too slowly to change the overall population much at all.
Our mosquito doomsday device gets around these problems by applying two innovations.
The Latest on: Gene drive
via Google News
The Latest on: Gene drive
- Fact check: These birthmarks are not indicators of a MTHFR gene mutation and other false claimson September 4, 2020 at 2:54 pm
Shared tens of thousands of times on Facebook, posts claim that three conditions found in infants – stork bites, sugar bugs, and sacral dimples – indicate a mutation in the MTHFR gene. The posts also ...
- Dr. Eugene Allen Makes History with Urgent Care Chain in Los Angeleson September 4, 2020 at 2:05 pm
Dr. Eugene Allen the first African American Franchisee of Multiple Urgent Care Facilities Across Los Angeles and Orange Counties LOS ANGELES (PRWEB) ...
- Gene editing 'not yet proven to be safe in embryos', official body warnson September 3, 2020 at 5:05 pm
Genetically editing a human embryo has not been proven to be safe, a major report into the future of creating so-called “designer babies” has warned. The specialist board behind the report stressed ...
- This Gene May Be Why Women with Alzheimer’s Disease Live Longer Than Menon September 3, 2020 at 3:16 pm
Women with Alzheimer’s disease tend to live longer than men with the disease — and a new study suggests that a gene on the X chromosome may help explain why.
- Mutations in the Same Gene Create Different Paths to Breast Cancer Drug Resistanceon September 3, 2020 at 10:39 am
Many patients with estrogen-positive breast cancer develop resistance to drugs called aromatase inhibitors. MSK researchers have discovered that mutations in a gene called FOXA1 cause the cancer cells ...
- Therapeutic benefit after intracranial gene therapy delivered during the symptomatic stage in a feline model of Sandhoff diseaseon September 3, 2020 at 9:00 am
Sandhoff disease (SD) is an autosomal recessive lysosomal storage disease caused by defects in the β-subunit of β-N-acetylhexosaminidase (Hex), the enzyme that catabolizes GM2 ganglioside. Hex ...
- Using CRISPR to improve viral vectors for gene therapyon September 3, 2020 at 8:00 am
To overcome preexisting immunity that cripples the adenovirus vectors used in gene therapy and vaccines, scientists at the University of Pittsburgh created a CRISPR-based system that briefly ...
- Taysha Gene Therapies guns for $100M IPO as it eyes 2020 clinical trialon September 3, 2020 at 7:55 am
Taysha Gene Therapies launched just four months ago, but it plans to ride the biotech wave to a $100 million IPO. It recently topped up its coffers with a $95 million series B, but, with plans to hit ...
- AAV gene therapy often leads to dorsal root ganglion pathology, show studieson September 2, 2020 at 10:48 pm
A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.
- Worldwide Gene Delivery Systems Industry to 2025 - North America Dominates the Market - ResearchAndMarkets.comon September 2, 2020 at 9:35 am
Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The gene delivery systems market studied was anticipated to grow with a CAGR of 7.3%, over the ...
via Bing News